According to a recent market study published by Growth Market Reports, titled, “Global Trans-anal Irrigation (TAI) Market By Type, By Bowel Dysfunction, By Application, By End User, and By Region: Size, Share, Trends and Opportunity Analysis, 2015-2030”, the market was valued at US$ 621.5 Million in 2021 and is expected to expand at a growth rate of 3.8% by 2030.

Trans-anal irrigation (TAI) has been employed for a variety of purposes since 1500 BC. TAI is used to treat constipation in children who have not responded to conservative treatment and to achieve fecal pseudo-continence. It is applied to both functional and congenital problems. TAI is applied using either the Peristeen (PT) or the Colotip (CT) methods, both of which are offered by Coloplast. Originally designed for stoma irrigations, the CT is a reusable plastic bag with an irrigation cone. PT is a rectal balloon attached to an irrigation bag that was first reported by Shandling and Gilmour. In order to maintain the catheter's position in the rectum, the rectal catheter was placed, and the balloon was inflated with air.

Get Sample Report @

One of the key future trends is the ongoing development of trans-anal irrigation systems that offer patients comfort and few risks when using balloon catheter devices. A trans-anal irrigation system has few complications. In comparison to other products, balloon catheter devices are linked to a lower risk of bowel perforation during anal irrigation.

Balloon catheter systems are manufactured for use over toilets and are suited for people who have trouble keeping a cone in place or need a better seal to inject the irrigation water, hence they are expected to be in high demand in the coming years. Similar to closed anal irrigation systems, bed systems are appropriate for those who cannot sit over the toilet. Balloon catheters are portable and adapt to a changing lifestyle.

Technological advancements in the global trans-anal irrigation (TAI) system are expected to drive the demand for the product. For instance, the Navina Smart system by Wellspect HealthCare features an electronically-driven pump with digital control.

Chronic constipation and fecal incontinence are common health problems in adults and children. Thus, manufacturers are involved in research activities to develop cutting-edge trans-anal irrigation devices that support effective bowel management and assist patients and healthcare professionals in avoiding chronic constipation. Adults are increasingly using anal irrigation devices, as they are likely to experience neurological conditions that result in fecal incontinence. Companies are concentrating on a number of strategies, such as R&D and mergers & acquisitions, to access regional and global markets. These factors are expected to create opportunities for key players.

Key Takeaways from the Study

  • Players in the global Trans-anal Irrigation (TAI) market include B. Braun SE, Coloplast Group, Qufora, Renew Medical Inc., Wellspect HealthCare, Convatec Group PLC, BD, Primed Halberstadt Medizintechnik GmbH, Runfold Plastics Ltd., and Consure MedicallStepan Company
  • On the basis of type, the global Trans-anal Irrigation (TAI) market is segmented into cone system, balloon catheter, and bed system. The cone system segment is expected to expand at 3.6% CAGR during the forecast period, owing to an increase in patient compliance and easy procedure. The cone system is easy-to-use equipment for geriatric patients with less complication.
  • On the basis of bowel dysfunction, the market is fragmented into irritable bowel syndrome (IBS), intestinal obstruction, and chronic constipation. The chronic constipation segment is anticipated to expand at a CAGR of 3.9% during the forecast period, owing to the rising number of hospitalization and complications among patients with chronic constipation.
  • On the basis of application, the global trans-anal irrigation (TAI) market is bifurcated into carried out on the toilet and carried out on the bed. In 1997, the Journal of Neurology published data about the percentage of patients affected by neurological bowel dysfunction. The increase in the prevalence of neurological bowel dysfunction cases and the rise in the usage of the bed system to treat bowel dysfunction fuels the segment.
  • On the basis of end-user, the global Trans-anal Irrigation (TAI) market is bifurcated into children and adults. The Department of Pediatric Gastroenterology published an article in 2017 stating that about 3% of children suffer from functional constipation. The rising number of patients suffering from functional constipation led to increased healthcare spending for treating functional constipation. In 2009, the US healthcare spending for functional constipation was USD 3.9 million.
  • On the basis of region, the global trans-anal irrigation (TAI) market is divided into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The market in the US is projected to expand at a CAGR of 4.1% during the forecast period, due to the rise in the number of patients affected by inflammatory bowel disease. According to an article published by the Crohn’s & Colitis Foundation of America (CCFA) in 2017, around 1.6 million patients suffer from inflammatory bowel diseases. Additionally, nearly 70,000 new cases are diagnosed in the US each year. Thus, the rise in incidences of inflammatory bowel disease increases the use of balloon catheters for trans-anal irrigation.

Report Scope

Report Metric


Market Value in 2021

US$ 624.5 Million

Market Growth Rate (from 2022 to 2030)


Historical Data

2015 to 2020

Base Year


Forecast Period

2021 - 2030

Units Considered

Value (US$ Million)

Market Segments

By Type, By Bowel Dysfunction, By Application, By End User, and By Region

Key Companies Profiled

B. Braun SE, Coloplast Group, Qufora, Renew Medical Inc, Wellspect HealthCare, Convatec Group PLC, BD, Primed Halberstadt Medizintechnik GmbH, Runfold Plastics Ltd., and Consure Medical

Customization Scope

Report customization available on request

Pricing and Purchase Options

Avail tailor-made purchase options to meet all research requirements.

Target Audience

  • Supply-side: Manufacturers and distributors
  • Demand Side: Hospitals, Clinics, and Research Laboratories
  • Regulatory Side: Concerned government authorities, and other approved regulatory bodies.